BeOne Medicines AG
ONC NASDAQHealthcare ★★★★★Latest Earnings Above forecast↑
Date
Aug 5, 2026
ET
EPS Est.
1.63
EPS Actual
2.05
Revenue Est.
$1.62B
Revenue Actual
$1.71B
Next Earnings Report
Date
Nov 5, 2026 · Thu
Time
Pre-market
Fiscal Period
FY2026 Q3
EPS Est.
1.90
Revenue Est.
$1.75B
Company Overview
BeOne Medicines AG (ticker ONC) is listed on NASDAQ with a market cap of about $40.02B. Its next earnings report (FY2026 Q3) is expected on Nov 5, 2026 (ET), Pre-market, with consensus EPS of 1.90. In the last 9 reported quarters, EPS beat consensus estimates 6 times.
Actual EPS TrendRecently15Term · Dec 31, 2022 → Aug 5, 2026
Dec 31, 2022Range: -30.54 ~ 2.05Aug 5, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 5, 2026 | -- | 1.63 | Above forecast↑2.05 | $1.62B | $1.71B |
| May 6, 2026 | -- | 0.73 | Above forecast↑1.96 | $1.44B | $1.51B |
| Feb 26, 2026 | -- | 1.60 | Below forecast↓0.58 | $1.47B | $1.5B |
| Nov 6, 2025 | -- | 0.72 | Above forecast↑1.09 | $1.45B | $1.41B |
| Aug 6, 2025 | -- | 0.48 | Above forecast↑0.84 | $1.44B | $1.32B |
| May 7, 2025 | -- | -0.71 | Above forecast↑1.22 | $1.25B | $1.12B |
| Feb 27, 2025 | -- | -0.88 | Below forecast↓-1.43 | $1.04B | $1.13B |
| Nov 12, 2024 | -- | -0.88 | Below forecast↓-1.15 | -- | $1B |
| Aug 7, 2024 | -- | -2.10 | Above forecast↑-1.15 | -- | $929.2M |
| Mar 31, 2024 | -- | -- | -2.41 | -- | $751.7M |
| Dec 31, 2023 | -- | -- | -25.53 | -- | $634.4M |
| Sep 30, 2023 | -- | -- | 2.01 | -- | $781.3M |
| Jun 30, 2023 | -- | -- | -3.64 | -- | $595.3M |
| Mar 31, 2023 | -- | -- | -3.34 | -- | $447.8M |
| Dec 31, 2022 | -- | -- | -30.54 | -- | $380.1M |
Original Filings (SEC)
10-Q2026-08-05 ↗
8-K2026-08-05 ↗
8-K2026-06-26 ↗
8-K2026-06-11 ↗
8-K2026-05-15 ↗
10-Q2026-05-06 ↗
8-K2026-05-06 ↗
8-K2026-04-14 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
